WallStreetZenWallStreetZen

NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James E. LevineChief Financial Officer2024-12-182,400$5.00
$12.00kBuy
James E. LevineChief Financial Officer2024-12-172,752$5.42
$14.90kBuy
James E. LevineChief Financial Officer2024-12-162,564$3.83
$9.82kBuy
Renee P. TannenbaumDirector2024-12-1210,000$3.42
$34.22kBuy
Gary W. PaceDirector2024-12-11350,115$2.60
$910.30kBuy
Gary W. PaceDirector2024-12-1111,500$2.60
$29.90kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Commodore Capital LP8.09%5,384,616$15.88MInstitution
Robert Merrill Hunter7.61%5,065,004$14.94MInsider
Ra Capital Management LP4.95%3,290,000$9.71MInsider
Bridger Management LLC4.46%2,968,115$8.76MInsider
Blackrock Inc4.27%2,840,909$8.38MInstitution
Gary W. Pace3.84%2,555,013$7.54MInsider
Pfizer Inc3.63%2,411,575$7.11MInstitution
Vanguard Group Inc3.43%2,284,917$6.74MInstitution
Orbimed Advisors LLC2.31%1,538,462$4.54MInstitution
Acorn Capital Advisors LLC2.17%1,442,308$4.25MInstitution

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF42.19%25.47%Net Buying
TVGN1.31%85.95%Net SellingNet Selling
DMAC15.70%64.32%Net BuyingNet Buying
INMB26.91%32.26%Net Buying
YMAB62.44%37.56%Net SellingNet Selling
View Top Biotech Stocks

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 42.19% institutional shareholders, 25.47% Cardiff Oncology insiders, and 32.34% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 7.61% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $14.08M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.